Reprogramming Strategies that Shape the Future of iPSC Therapies
- Selecting an optimized iPSC reprogramming strategy to accelerate timelines while ensuring safety
- Evaluating starting cell types for iPSC reprogramming and their influence on downstream differentiation potential
- Planning for scalability in both autologous and allogeneic iPSC-based therapy development